Skip to main content
Top
Published in: Current Hematologic Malignancy Reports 1/2018

01-02-2018 | Stem Cell Transplantation (R Maziarz, Section Editor)

Twitter Use in the Hematopoietic Cell Transplantation Community

Authors: Sagar S. Patel, Navneet S. Majhail

Published in: Current Hematologic Malignancy Reports | Issue 1/2018

Login to get access

Abstract

Purpose of Review

Social media has revolutionized the access and exchange of information in healthcare. The microblogging platform Twitter has been used by blood and marrow transplant physicians over the last several years with increasing enthusiasm. We review the adoption of Twitter in the transplant community and its implications on clinical care, education, and research.

Recent Findings

Twitter allows instantaneous access to the latest research publications, developments at national and international meetings, networking with colleagues, participation in advocacy, and promoting available clinical trials. Additionally, Twitter serves as a gateway for resources dedicated to education and support for patients undergoing transplantation.

Summary

We demonstrate the utilization and various applications in using Twitter among hematopoietic cell transplant healthcare professionals, patients, and other affiliated stakeholders. Professionalism concerns with clinician use of such social media platforms, however, also exist. Overall, Twitter has enhanced and increased the opportunities for engagement in the transplant community.
Literature
2.
go back to reference Abuhadra N, Majhail NS, Nazha A. Impact of social media for the hematologist/oncologist. Semin Hematol 2017; 54: 193–197. Abuhadra N, Majhail NS, Nazha A. Impact of social media for the hematologist/oncologist. Semin Hematol 2017; 54: 193–197.
4.
go back to reference Katz MS, Utengen A, Anderson PF, et al. Disease-specific hashtags for online communication about cancer care. JAMA Oncol. 2016;2:392–4.CrossRefPubMed Katz MS, Utengen A, Anderson PF, et al. Disease-specific hashtags for online communication about cancer care. JAMA Oncol. 2016;2:392–4.CrossRefPubMed
5.
go back to reference •• Pemmaraju N, Thompson MA, Qazilbash M. Disease-specific hashtags and the creation of Twitter medical communities in hematology and oncology. Semin Hematol. 2017;54:189–92. Provides a framework for disease-specific hashtags in hematology and oncology. CrossRefPubMed •• Pemmaraju N, Thompson MA, Qazilbash M. Disease-specific hashtags and the creation of Twitter medical communities in hematology and oncology. Semin Hematol. 2017;54:189–92. Provides a framework for disease-specific hashtags in hematology and oncology. CrossRefPubMed
9.
go back to reference Ciprut S, Curnyn C, Davuluri M, et al. Twitter activity associated with U.S. news and world report reputation scores for urology departments. Urology. 2017;108:11–6.CrossRefPubMed Ciprut S, Curnyn C, Davuluri M, et al. Twitter activity associated with U.S. news and world report reputation scores for urology departments. Urology. 2017;108:11–6.CrossRefPubMed
10.
go back to reference •• Pemmaraju N, Mesa RA, Majhail NS, Thompson MA. The use and impact of Twitter at medical conferences: best practices and Twitter etiquette. Semin Hematol. 2017;54:184–8. Discusses the how significantly Twitter has changed medical conference participation. CrossRefPubMed •• Pemmaraju N, Mesa RA, Majhail NS, Thompson MA. The use and impact of Twitter at medical conferences: best practices and Twitter etiquette. Semin Hematol. 2017;54:184–8. Discusses the how significantly Twitter has changed medical conference participation. CrossRefPubMed
13.
go back to reference • Thompson MA, Younes A, Miller RS. Using social media in oncology for education and patient engagement. Oncology (Williston Park). 2012;26:782. 784–785, 791. This paper discusses social media use in oncology for the purposes of education and patient engagement. • Thompson MA, Younes A, Miller RS. Using social media in oncology for education and patient engagement. Oncology (Williston Park). 2012;26:782. 784–785, 791. This paper discusses social media use in oncology for the purposes of education and patient engagement.
14.
go back to reference Shay DF. Physician use of social media: navigating the risks. Establish social media guidelines to protect health information, and reputation of practice and physicians. Med Econ. 2014;91:44–6.PubMed Shay DF. Physician use of social media: navigating the risks. Establish social media guidelines to protect health information, and reputation of practice and physicians. Med Econ. 2014;91:44–6.PubMed
Metadata
Title
Twitter Use in the Hematopoietic Cell Transplantation Community
Authors
Sagar S. Patel
Navneet S. Majhail
Publication date
01-02-2018
Publisher
Springer US
Published in
Current Hematologic Malignancy Reports / Issue 1/2018
Print ISSN: 1558-8211
Electronic ISSN: 1558-822X
DOI
https://doi.org/10.1007/s11899-018-0434-1

Other articles of this Issue 1/2018

Current Hematologic Malignancy Reports 1/2018 Go to the issue

T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

NK/T Cell Lymphoma: Updates in Therapy

T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

Immunologic Milieu of Mature T-Cell and NK-Cell Lymphomas—Implications for Therapy

T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

Central Nervous System Involvement in Peripheral T Cell Lymphoma

T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL)

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.